Robert Nelsen - Director, 10%+ Owner at Lyell Immunopharma, Inc.

Issuer-level insider activity

Role: Director, 10%+ Owner
Issuer ticker: LYEL on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Robert Nelsen since 04 Aug 2025

Reported holdings for Robert Nelsen in Lyell Immunopharma, Inc.

Form 4 holding Director, 10%+ Owner

Lyell Immunopharma, Inc.

Security class: Common Stock
Shares / value: 18,206,358
Estimated value: $41,510,496
Report date: 14 Jun 2024
Price: $2.28
Ownership: ARCH Venture Fund IX,L.P.

Form 4 holding Director, 10%+ Owner

Lyell Immunopharma, Inc.

Security class: Common Stock
Shares / value: 18,206,358
Estimated value: $41,510,496
Report date: 14 Jun 2024
Price: $2.28
Ownership: ARCH Venture Fund IX Overage, L.P.

Form 4 holding Director, 10%+ Owner

Lyell Immunopharma, Inc.

Security class: Option (right to buy)
Shares / value: 130,000
Estimated value
Report date: 14 Jun 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Robert Nelsen in Lyell Immunopharma, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .